rs151310594
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The ENST00000284601.4(PPP1R3A):c.2267C>T(p.Pro756Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000619 in 1,613,408 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00050 ( 1 hom. )
Consequence
PPP1R3A
ENST00000284601.4 missense
ENST00000284601.4 missense
Scores
4
8
7
Clinical Significance
Conservation
PhyloP100: 6.58
Genes affected
PPP1R3A (HGNC:9291): (protein phosphatase 1 regulatory subunit 3A) The glycogen-associated form of protein phosphatase-1 (PP1) derived from skeletal muscle is a heterodimer composed of a 37-kD catalytic subunit and a 124-kD targeting and regulatory subunit. This gene encodes the regulatory subunit which binds to muscle glycogen with high affinity, thereby enhancing dephosphorylation of glycogen-bound substrates for PP1 such as glycogen synthase and glycogen phosphorylase kinase. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0126564205).
BP6
Variant 7-113878825-G-A is Benign according to our data. Variant chr7-113878825-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 393402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R3A | NM_002711.4 | c.2267C>T | p.Pro756Leu | missense_variant | 4/4 | ENST00000284601.4 | NP_002702.2 | |
PPP1R3A | XM_005250473.4 | c.1664C>T | p.Pro555Leu | missense_variant | 5/5 | XP_005250530.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R3A | ENST00000284601.4 | c.2267C>T | p.Pro756Leu | missense_variant | 4/4 | 1 | NM_002711.4 | ENSP00000284601 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00171 AC: 260AN: 151942Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
260
AN:
151942
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000926 AC: 232AN: 250464Hom.: 0 AF XY: 0.000850 AC XY: 115AN XY: 135346
GnomAD3 exomes
AF:
AC:
232
AN:
250464
Hom.:
AF XY:
AC XY:
115
AN XY:
135346
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000504 AC: 736AN: 1461348Hom.: 1 Cov.: 71 AF XY: 0.000488 AC XY: 355AN XY: 726974
GnomAD4 exome
AF:
AC:
736
AN:
1461348
Hom.:
Cov.:
71
AF XY:
AC XY:
355
AN XY:
726974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00173 AC: 263AN: 152060Hom.: 0 Cov.: 33 AF XY: 0.00164 AC XY: 122AN XY: 74332
GnomAD4 genome
AF:
AC:
263
AN:
152060
Hom.:
Cov.:
33
AF XY:
AC XY:
122
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
91
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Monogenic diabetes Benign:2
Likely benign, criteria provided, single submitter | research | Biomedical Genomics and Oncogenetics Laboratory, Institut Pasteur de Tunis, University Tunis El Manar | Apr 25, 2022 | - - |
Likely benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Oct 31, 2017 | ACMG criteria: PP3 (7 predictors), BP4 (3 predictors), BS2 (23 cases and 22 controls in type2diabetesgenetics.org)=likely benign - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at